Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.
FibroGen, Inc. Announces Phase 2 Data Supporting Longer-Term Safety And Efficacy Profile Of FG-3019 In Patients With Idiopathic Pulmonary Fibrosis
TSRI Assistant Professor Ryan Shenvi, an alumnus of TSRI’s graduate program, focuses on creating new chemical choreography.
Work led by the Loring lab at TSRI and the Lane lab at the University of Utah shows that human stem cells can help mice regain mobility after a crippling disease similar to multiple sclerosis.
The findings from the Paulson lab at TSRI and the Cummings lab at Emory shed light on how our immune system works and on potential new directions for antibiotic development.
The ceremony honored 38 graduating biology and chemistry students and honorary degree recipient Jack E. Dixon, a pioneering biochemist.
LA JOLLA—The Salk Institute’s award-winning Education Outreach program recently earned national recognition when it received a two-year pilot grant through the AAAS’s new National STEM (Science, Technology, Engineering and Math) Volunteer Program. The grant, one of just seven the association awarded, will help bring San Diego-area high school science teachers together with Salk scientists to develop curriculum based on the state-of-the-art research taking place at the Institute.
Vapors also hurt immune cells, says study by UCSD, VA researchers.
Lumena Pharmaceuticals Inc. is being snapped up by Irish drugmaker Shire PLC for $260 million, scrapping the San Diego biotech’s plan to raise $75 million in an initial public offering.
Sanford-Burnham hosted the sixth annual Bring It! event at the San Diego Hall of Champions in San Diego, Calif., on Thursday, May 1, 2014, to raise funds for medical research. As in prior years, the event was an incredible success. The evening kicked off with a bang as guests walked down an AstroTurf carpet lined